Detalles de la búsqueda
1.
Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020-2023).
Bioorg Chem;
143: 107042, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38118298
2.
Antidiabetic potential of thiazolidinedione derivatives with efficient design, molecular docking, structural activity relationship, and biological activity: an update review (2021-2023).
Mol Divers;
2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253844
3.
Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studies.
Arch Pharm (Weinheim);
357(4): e2300296, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38196114
4.
Mechanistic insight and structure activity relationship of isatin-based derivatives in development of anti-breast cancer agents.
Mol Cell Biochem;
2023 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37329491
5.
Quinoline derivatives volunteering against antimicrobial resistance: rational approaches, design strategies, structure activity relationship and mechanistic insights.
Mol Divers;
27(4): 1905-1934, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36197551
6.
Design, synthesis, and biological evaluation of novel morpholinated isatin-quinoline hybrids as potent anti-breast cancer agents.
Arch Pharm (Weinheim);
355(2): e2100368, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34783073
7.
Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer.
Mol Divers;
25(1): 603-624, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32886304
8.
Estradiol attenuates ischemia reperfusion-induced acute kidney injury through PPAR-γ stimulated eNOS activation in rats.
Mol Cell Biochem;
453(1-2): 1-9, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30194582
9.
Estradiol mitigates ischemia reperfusion-induced acute renal failure through NMDA receptor antagonism in rats.
Mol Cell Biochem;
434(1-2): 33-40, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28432550
10.
Pioglitazone ameliorates renal ischemia reperfusion injury through NMDA receptor antagonism in rats.
Mol Cell Biochem;
417(1-2): 111-8, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27206738
11.
2,4-Diarylpyrano[3,2-c]chromen-5(4H)-ones as Antiproliferative Agents.
Chem Pharm Bull (Tokyo);
64(5): 399-409, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27150472
12.
Recent advances in antifungal drug development targeting lanosterol 14α-demethylase (CYP51): A comprehensive review with structural and molecular insights.
Chem Biol Drug Des;
102(3): 606-639, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220949
13.
Shikonin derivatives as potent xanthine oxidase inhibitors: in-vitro study.
Nat Prod Res;
37(16): 2795-2800, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36214700
14.
Pathogenesis of Alzheimer's Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential.
ACS Chem Neurosci;
14(18): 3291-3317, 2023 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683129
15.
Synthetic heterocyclic derivatives as promising xanthine oxidase inhibitors: An overview.
Chem Biol Drug Des;
100(3): 443-468, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35763448
16.
Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001-2021).
Expert Opin Ther Pat;
32(10): 1079-1095, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36189616
17.
Donepezil-Inspired Multitargeting Indanone Derivatives as Effective Anti-Alzheimer's Agents.
ACS Chem Neurosci;
13(6): 733-750, 2022 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35195392
18.
Discovery of potent inhibitors for Mpro enzyme of SARS-COV2 by multi-stage in-silico screening of Alkannin/shikonin.
Nat Prod Res;
36(18): 4804-4808, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34906016
19.
Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study.
Phytomed Plus;
1(4): 100083, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403086
20.
Xanthine oxidase inhibitors: patent landscape and clinical development (2015-2020).
Expert Opin Ther Pat;
30(10): 769-780, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32797760